SLXN

Silexion Therapeutics Corp - Ordinary Shares (SLXN)

About Silexion Therapeutics Corp - Ordinary Shares (SLXN)

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.

Details

Daily high

$0.55

Daily low

$0.50

Price at open

$0.54

52 Week High

$22.36

52 Week Low

$0.47

Market cap

2.1M

Dividend yield

0.00%

Volume

9,584

Avg. volume

91,821

P/E ratio

-.04

Silexion Therapeutics Corp - Ordinary Shares News